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PART – 1 
  
 INTRODUCTION 
The first reported use of fetal membranes in skin transplantation 
was by Davis in 1910. In 1913, Sabella used amniotic membrane on 
burned and ulcerated skin surfaces and observed lack of infection, 
marked decrease in pain, and increased rate of re-epithelialization of 
traumatized skin surface. Others have demonstrated the use of amniotic 
membrane as a biological dressing for open wounds including burns and 
chronic ulceration of the legs.(1) 
The first use of amniotic membrane transplantation (AMT) in 
ophthalmology was by De Roth in 1940 who reported partial success in 
the treatment of conjunctival epithelial defects after symblepharon. 
Sorsby and Symons in 1946 found that patients with caustic burns of the 
conjunctiva with corneal involvement could be treated successfully 
using amniotic membrane. Little else regarding AMT appeared in the 
ophthalmic literature until 1995 when Kim and Tseng used AMT for 
ocular surface reconstruction of severely damaged corneas in a rabbit 
model. Since that experimental study, AMT has been used for persistent 
corneal epithelial defects, corneal ulcers,leaking filtering blebs after 
glaucoma surgery, pterygium surgery, conjunctival surface 
 reconstruction,  bullous keratopathy,  chemical or thermal burns, ocular  
surface reconstruction with or without limbal stem cell grafting,  and in 
patients with ocular cicatricial pemphigoid or Stevens-Johnson  
syndrome(5). 
  
 ANATOMY OF THE CORNEA 
The cornea is a transparent,  vascular watch glass like structure 
forming the anterior one sixth of the eyeball. It forms the principal 
refractive surface, contains the intraocular pressure and provides a 
protective interface with the environment. These functions can be sub-
served by virtue of a sub-structural organization. Histologically, the 
cornea is composed of five layers (Fig.1). 
           Epithelium 
Bowman’s membrane 
Stroma or substantia propria 
Descemet’s membrane 
Endothelium 
 
CORNEAL EPITHELIUM: 
           It is stratified squamous and nonkeratinized.It is 50-90 micron  
thick and consists of 5 or 6 layers of nucleated cells.The epithelial cells  
are arranged in three layers. 
  
 DEEP ZONE: 
It consists of single layer of basal columnar cells and forms the 
germinative zone. 
MIDDLE ZONE: 
It comprises of 2 to 3 layers of polyhedral cells called wing cells 
which are convex anteriorly and cap the basal cells. 
SUPERFICIAL ZONE: 
It has 2 to 3 layers of flattened nucleated cells called squamous 
cells. 
The integrity of the epithelium plays an important role in 
protecting the cornea against most of the pathogens responsible for 
corneal ulcers. Any disruption in the epithelium predisposes the cornea 
to infection. 
BOWMAN’S LAYER: 
      It is a narrow,  acellular, homogenous zone, 8 to 14 micron thick, 
immediately subjacent to the basal lamina of the epithelium. It is 
relatively resistant to trauma due to the compact arrangement of 
collagen but once destroyed, it can’t be regenerated. 
 STROMA OR LAMINA PROPRIA: 
It is around 560 microns thick (90% of the thickness of the 
cornea) and comprises of regularly arranged lamellae of collagen 
bundles in a proteoglycan ground substance with cells called 
keratocytes. Collagen makes up 71% of the dry weight of the cornea. 
One of the unique features is the regular alignment  of collagen fibrils. 
Another unique feature is the consistent diameter of the collagen fibrils 
(27-35nm).The  relatively small diameter of the corneal collagen fibres 
is the result of elevated levels of type 5 collagen. It makes up 15-20% of 
the total. The size also depends on the association of the fibrils with 
proteoglycans. Decorin, lumican and fibromodullin are all known to 
associate with collagen fibrils and limit the size of the fibril. The 
lamellar arrangement is less precise in the anterior stroma. 
DESCEMET’S MEMBRANE 
 It is a 10-12 micron thick basal lamina produced by the 
endothelium. It’s peripheral termination is marked by the Schwalbe’s 
line. The major protein is type four collagen. Descemet’s membrane 
readily regenerates following injury. 
  
 ENDOTHELIUM: 
The endothelium is a single layer of cells located in the posterior 
part of the cornea. It permits the passage of nutrients from the aqueous 
humor into the cornea. The endothelium is the major cell layer 
responsible for maintaining the relatively low level of stromal hydration 
necessary for corneal transparency.(7) 
  
  
 
 
  
Fig.1 (a & b) - Anatomy of the cornea 
  
 PATHOLOGY OF CORNEAL WOUND HEALING 
The primary function of the corneal epithelium is to form a barrier 
to invasion of the eye by pathogens and for uptake of excess fluid from 
the stroma. Injury to the cornea may be accidental or iatrogenic in 
origin. After abrasion the first 4-6 hours after  epithelial injury is the 
initial latent phase where no appreciable decrease in size of the wound 
occurs. The basal and squamous cells in the vicinity of the wound show 
thickening and separation. Neutrophils accumulate along the wound 
edge 3 hours after the injury as does the thinning of the epithelium to a 
single layer. The leading edge of the migrating cells is only one cell 
thick. The cells enlarge and the epithelial sheets begin to migrate by 
amoeboid movements across the defect until it is completely covered. A 
circumferential migration of 3-6 leading fronts progressed towards the 
center. They meet and merge and form a multilayered sheet. A wound of 
around 6 mm in diameter closes within 48 hours and the rate of 
migration is 60-80 micro meters per hour.  
The basal cells play a key role, the source of which is the limbal 
basal stem cells. The centripetal migration was due to the inward 
drawing of cells by preferential desquamation of central corneal 
epithelial cells. It is interesting to note that the healing rates for larger 
 defects were more rapid than for smaller defects. This is attributed to 
greater proliferative response of cells in the peripheral cornea and 
limbus than the central cornea. An important aspect of wound healing is 
the reformation of adhesion complexes to the underlying connective 
tissue. Initial linkage is between cytoplasmic actin filaments of the 
migrating epithelial cells to the extracellular matrix proteins like 
fibronectin, fibrinogen-fibrin, laminin, tenascin, and integrin. 
Reformation of adhesion complexes  gradually occurs from the 
periphery to the center.  
Stromal wound healing: 
 After injury,keratocytes are capable of phagocytosis of collagen 
fibrils and synthesis and secretion of collagen, glycosaminoglycan 
ground substance , collagenase and collagenase inhibitors. Within hours 
a cascade of response to cytokine occur, polymorphonuclear cells occur 
around areas of cellular necrosis. Immediately following injury initial 
keratocyte apoptosis occurs, within 12 hours proliferation and migration 
of residual activated keratocyte occur that repopulate the depleted 
stroma. TGF β reduces corneal fibrosis. The healing process is initiated 
by multiple cytokines and growth factors like IL-1, TNFα, Bone 
morphogenic proteins 2 and 4, Epidermal growth factor(EGF), Platelet 
derived growth factor(PDGF) from the corneal epithelium and basement 
 membrane. There is also removal of damaged tissue by the 
plasminogen-activator/plasmin system, metalloproteinases (MMPs). 
These MMPs from polymorphonuclear sites are involved in epithelial 
migration, initial stromal degradation and removal of damaged tissue. 
MMP2 is involved in the prolonged process of collagen remodeling in 
the stromal repair tissue. MMP9 in the epithelium is believed to be 
involved in the degradation of basement membrane that precedes 
corneal ulceration, as well as controlling the resynthesis of basement 
membrane.  
Return of normal structure and function may take months or even 
years, depending upon the nature of injury or surgery.(1,2) 
Factors protecting the cornea: 
 An intact corneal epithelial surface with its tight junctions formed 
by desmosomes and hemi desmosomes protects the surface of eye from 
infectitious agents. The eyelid provides a physical barrier to the 
organism. The tear film contains antimicrobial enzymes, 
immunoglobulins, lysozyme, lactoferrin. The normal ocular 
floraprovides a balance to prevent overgrowth of exogenous organisms. 
The conjunctiva contains subepithelial mucosal associated lymphoid 
tissue. 
  Healing Response To Corneal Infection 
 In keratitis, entry of organisms result in diffusion of toxins and 
enzymes. Polymorphonuclear leukocytes arrive at the corneal wound 
site. Stromal damage from bacterial and neutrophil enzymes facilitate 
bacterial invasion of cornea. There is a progressive tissue necrosis and 
sloughing of epithelium and stroma which varies with the virulence of 
the organism and toxin. The necrotic base of the ulcer is surrounded by 
heaped up tissue. The host cellular and humoral defence mechanisms 
retard bacterial replication, promote phagocytosis and halt destruction of 
stromal collagen. 
 In the healing phase, the epithelium resurfaces the central area of 
ulceration and the necrotic stroma is replaced by scar tissue produced by 
fibroblast. These fibroblasts are derived from keratocytes. New 
epithelium slowly resurfaces irregular bases. Bowmens layer does not 
regenerate bur replaced with fibrous tissue. New blood vessel are 
directed towards area of ulceration to deliver humoral and cellular 
components to promote healing. These gradually disappear and may 
leave ghost vessels. The fibrous scar tissue results in corneal opacity 
which may gradually fade over time.(7,25) 
 EPIDEMIOLOGY OF BACTERIAL AND FUNGAL CORNEAL 
ULCERS 
 FUNGAL: 
           In the Northern part of India, Nepal and Coastal Karnataka 
Aspergillus species are found to be frequently involved whereas in 
Southern part of India, Fusarium species is reported as the leading cause 
of keratitis. 
          In general ,Aspregillus species are common in India as shown by 
many studies. Candida is very rare in India as causative organism except 
in eyes predisposed to it. 
Fungi common in cooler parts of the world is Candida whereas  
Aspergillus and Fusarium are common in warmer climates. Fungi rarely 
infect intact cornea. They are opportunistic pathogens. They infect when 
host immunity is deranged either locally or when systemic immune 
deficiency exists. 
Fungi are ubiquitous, their light spores produced in huge numbers 
are disseminated and have remarkable ability to germinate and grow on 
almost any organic substance. 
 Fusarium species are primarily plant pathogens and 
keratomycosis caused by them are common in agricultural workers. 
BACTERIAL: 
There are four principal groups of bacteria involved; Micrococcus 
(staphylococcus, micrococcus), the streptococcus species, the 
pseudomonas species and the enterobactericiae (proteus and klebsiella). 
Ambient temperature and humidity determine the organism in the 
environment(3). 
Streptococcus species is the commonest isolate in South India. 
Staphylococcus is among the frequent organism in the United  States. 
Pneumococcus is associated with chronic dacryocystitis. Pseudomonas 
occurs in soft contact lens users. Moraxella in malnourished individuals. 
Neiserria can cause keratitis secondary to conjunctivitis. Perforation is 
common. A typical mycobateria can cause keratitis following Lasik. 
Neiserria gonorrhea, Corynebacterium and H.Influenza can 
penetrate intact epithelium. 
  
 PATHOGENESIS OF CORNEAL ULCERS 
The epithelium plays an important part in protecting the cornea 
against most pathogens.Any breach in the epithelium will predispose  
the cornea to infection. The pathogenic mechanisms of fungi include, 
1. Direct physical damage caused by invasion and growth of fungal 
elements. 
2. Damage from infiltrating leucocytes. 
3. Damage produced by fungal toxins and enzymes. 
In corneal fungal infections, clinical manifestation may occur as 
quickly as 24-48 hours or may be delayed for 10-20 days, potentially 
allowing the extensive fungal replication before deduction by the host. 
Infiltration of the host leucocytes particularly neutrophils is an 
important component of corneal damage produced in keratomycosis. 
Fungal hyphae are large enough to preclude ingestion by neutrophils, 
however neutrophils are known to destroy fungal hyphae and probably 
also damage surrounding tissue by frustrated phagocytosis with 
consequent extracellular release of lysosomal enzymes and oxygen 
metabolites. 
 Though a breach in the epithelium is essential for penetration, 
there are certain bacteria that can penetrate intact epithelium like 
N.Gonorrhoea, N.menigitides, C.diphtheriae  and H.influenza. 
In the pathogenesis of bacterial ulcers there are various factors 
which play a role. Adhesins are microbial proteins that adhere to the 
host cell and promote entry into the cell, induce cytokine production and 
may act as toxins directly. Pseudomonas has many virulence factors; 
Pili, fimbriae and flagella for adherence to the host cell and also help in 
bacterial motility important for bacterial dissemination of infection and 
also products like elastase and protease. In addition Pseudomonas and 
N.Gonorrhoeae is guided by glycocalyx a biological slime that enables 
them to adhere to susceptible cells, producing slime aggregates that are 
resistant to phagocytosis. In addition lysosomal enzymes and oxidative 
substances produced by neutrophils, keratocytes and epithelial cells also 
contribute to the destruction. Lipopolysaccharide composing the 
exotoxin in the cell wall also play a role.  
 
 
 
 CLINICAL FEATURES 
SYMPTOMS: 
The rich innervation of the cornea makes pain the most common 
symptom. Movement of the eyelids over ulcerated corneal epithelium  
intensifies the pain. 
There is a variable decrease in vision and also associated 
watering, photophobia and blepharospasm. Discharge is usually rare 
unless there is an associated conjunctivitis such as with gonococcus, 
pnemococcal and Haemophilus infections. 
FUNGAL KERATITIS (Fig.2) 
Keratitis caused by filamentous fungi: 
1. More common in young individuals involved in outdoor activities 
2. There is always a history of trauma with vegetable matter. 
3. Incubation period is 24-48 hrs, it may involve any area of cornea 
4. No evidence of prior ocular surface disorder like dry eyes, herpes or 
neuroparalytic keratitis is present.(2) 
 SIGNS: 
1. Greyish white infiltrate with hyphate margins elevated above the 
surface of cornea, surrounded by satellite lesions. 
2. Ulcer base may have a dry texture. 
3. Ulcer margins are irregular and elevated; may demonstrate 
irregular fine,linear infiltration branching into the surrounding 
cornea. 
4. Satellite lesions are discrete, stromal abscesses that surround the 
ulcer and are separated by clear cornea. 
5. Clear endothelial plaques are seen composed of inflammatory 
cells. 
6. Immune ring composed of antigen-antibody complex. 
7. Hypopyon is commonly associated feature even with a small ulcer 
but is not specific. 
Keratitis caused by non-inflamentous fungi: 
 This occurs commonly and exclusively in eyes with pre-existing 
corneal surface abnormalities like keratitis sicca, neuroparalytic 
keratitis, herpes affected eyes(8). 
 1. Ulcers usually occurs at the area of exposure; at the junction of 
superior 2/3 and inferior 1/3. 
2. Keratitis is more localized ,may have an expanding, small discrete 
infiltrate. 
3. No hyphate margins and edges not feathery. 
4. Satellite lesions are not usually seen 
BACTERIAL ULCERS (Fig.3) 
1. An epithelial defect with underlying stromal infiltrate 
2. An anterior chamber reaction and a hypopion which is 
characteristically sterile  and mobile. 
3. The base is wet 
4. Gram positive cocci cause round ulcers with grayish white 
infiltrates  with distinct borders and minimal surrounding edema. 
5. S.pneumoniae presents with a deep, oval central ulcer with 
serpiginous edges, a classic serpiginous corneal ulcer. 
6. Severe conjunctival hyperemia and chemosis in Nieserria. 
7. Nocardia shows crystalline bodies 
8. Dark hypopion with elevated intraocular pressure in Listeria(7). 
  
  
  
Fig.2 - Fungal corneal ulcer 
 
 
 
                              Fig.3 - Bacterial ulcer 
  
 
 
                   Table – 1 : Classification of ulcer severity 
FEATURE MILD MODERATE SEVERE 
Size Of Ulcer (mm) <2 2-5 >5 
Depth Of Ulcer (%) <20 20-50 >50 
Infiltrate Superficial 
Extension  
Upto  
Mid Stroma 
Deeper  
Than  
Mid Stroma 
Scleral Involvement Not Involved Not Involved 
May Be 
Involved 
 
  
 TREATMENT OF CORNEAL ULCERS 
MEDICAL 
ANTIFUNGALS 
Amphotericin B: 
 It is a polyene antibiotic derived from strains Streptomyces 
nodosus. 
Mechanism of action 
 The antibiotic binds to ergosterol present in the cell membranes, 
increase the permeability of cytoplasmic membranes, thereby permitting 
leakage of essential intracellular constituents. It is fungicidal at high 
concentration and fungistatic at low concentration. 
Natamycin: 
 This is a small polyene antibiotic first isolated in 1958. 
Mechanism of action 
 It binds to ergosterol present in the cell membranes, increase the 
permeability of cytoplasmic membranes, thereby permitting leakage of 
essential intracellular constituents.  
 Voriconazole: 
It inhibits fungal cytochrome-P450 mediated 14α lanosterol 
demethylation mediated ergosterol synthesis present in the fungal cell 
wall. Fluconazole is another azole derivative used. 
Chlorhexidine: 
Mechanism of action 
 It acts by attacking and rupturing the cell membranes. It inhibits 
both cation transport and membrane bound ATP in the cell membrane. 
ANTIBACTERIALS 
Flouroquinolones: 
They inhibit the action of bacterial DNA gyrase an enzyme 
essential for bacterial DNA synthesis. The commercially available 
flouroquinolones are highly ffective against pseudomonas aeruginosa  
and strains resistant to other agents. 
Aminoglycosides: 
They have a selective affinity for the bacterial 30s and 50s 
ribosomal subunits to produce a non-functional 70s initiation complex 
 that inturn results in the inhibition of bacterial cell protein synthesis. 
Commonly amikacin and gentamycin are used. They are effective 
against aerobic and faucultative gram negative bacilli. 
Cephalosporins: 
          They inhibit the third and final stage of bacterial cell wall 
synthesis by preferentially binding  to one or more penicillin binding 
proteins that are in the cytoplasmic membrane. Cephazolin and 
ceftazidime is commonly used. Fortified preparations are generally 
used. Intrastomal and intracameral antibiotics are also being tried. 
SURGICAL THERAPY: 
In case there is a perforation, 
• Cyanoacrylate glue may be tried for perforations less than 3mm 
• For larger perforations a patch graft may be done. 
• Penetrating keratoplasty is indicated in either medical treatment      
failures, in case of impending perforations and frank perforations 
more than 2mm. 
 In this procedure the entire thickness of the cornea is removed and 
replaced with an appropriate size corneal button from the donor. The 
procedure by itself has many  complications. 
Conjunctival flaps 
         It is generally indicated when medical therapy and surgery like 
amniotic membrane transplantation, patch grafting or penetrating 
keratoplasty fail. It may be partial or complete. The flap should cover 
the diseased area tension on the flap should be avoided to prevent 
retraction. It should not contain Tenon’s membrane. Any hole in the flap 
compromises the success of the procedure. The cornea under the flap 
should be mechanically debrided. The flap should be atleast one mm 
larger than the lesion on the cornea. One should not compromise the 
integrity of the flap be needling into the area of the intended flap. A 
combination of gentle blunt and sharp dissection is used with particular 
attention to avoid grasping the conjunctiva. A partial flap may be Van 
Lint hood peripheral flap, Racquet and bucket handle flap. Total 
conjuntival flap or Gunderson’s flap. A  peritomy is done, the upper 
forniceal conjunctiva has a larger area as the upper the fornix is deep, 
the distance from the limbus to limit  of the upper fornix is usually  
16-18mm.The flap is sutured to the sclera. The  area above the upper 
 limbus can be left uncovered, its epithelializaion is usually very rapid 
and complicated. 
 The results are usually very good leading to stabilization of the 
cornea, a reduction of inflammation and pain. The conjunctiva 
transparent within 8 weeks. 
Complications include button holes in the flap, necrosis of the 
flap and corneal melting and necrosis under the flap. 
Amniotic membrane grafts are becoming very popular now. 
  
 AMNIOTIC MEMBRANE GRAFTING 
Amniotic membrane transplantation is indicated for numerous 
ocular surface disorders, the spectrum of which has been expanding 
recently. The first report on the use of amniotic membrane for ocular 
disorders was by DeRoth in 1940. 
ANATOMY OF THE AMNIOTIC MEMBRANE: 
    It has five layers, 
           Epithelium 
           Basement membrane 
           Avascular connective tissue 
                     Compact layer 
                     Fibroblast layer 
                     Spongy layer 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig4 Anatomy of the Amniotic membrane  
 
 
  
 
Fig 5 Amnion as part of the placenta 
 
 
 
 
 
 
 The thickness of the membrane is 0.02-0.5mm.The compact layer 
is the strongest. The fibroblast layer is the thickest.(fig4) 
FUNCTION: 
There is growing evidence that biologic factors  including 
collagen and cytokines may make a major difference  between a soft 
contact lens and amniotic membrane. The amniotic membrane is 
believed to provide a superior substrate for migration of epithelial cells, 
reinforce adheshion of basal epithelial cells, promote epithelial 
differentiation, prevents apoptosis of epithelial cells and reduces 
neovascularization and fibrosis by reduction of inflammatory cell 
infiltration. 
Both collagen four and seven, components of corneal and 
conjunctival epithelial basement membrane are present in the basement 
membrane of amniotic membrane. In addition, amniotic membrane 
contains collagen three, one, two, five, fibronectin and laminin(15). 
Cytokines promote epithelialization and reduce inflammation, scarring 
and neovascularization. They are found in both the epithelium and 
stroma but believed to be synthesized predominantly by the epithelium. 
They are also present in cryopreserved amniotic membrane and 
 approximately 50% of the epithelial cells can be viable for several 
months. Hence it is possible that the amnion epithelial cells continue to 
produce cytokines after transplantation. Nerve growth factor, epidermal 
growth factor, keratocyte growth factor and hepatocyte growth factor  
may play a role in promoting epithelialization. The mechanism by which 
it reduces scarring, inflammation and angiogenesis are more complex. It 
uniquely suppresses transforming growth factor β signaling resulting in 
reduction in fibroblasts and scarring. It also traps inflammatory cells of 
the monocyte macrophage system. Fresh human amniotic cells produce 
antiangiogenic agents, interleukin 1 receptor antagonist, all four matrix 
metalloproteinase inhibitors, interleukin ten and thrombospondin(24). 
IMMUNE PREVILIGE: 
Unlike other allograft transplantation  it does not require the 
administration of systemic immunosuppressive therapy to prevent 
immune rejection. The amniotic membrane typically dissolves in 3-5 
weeks. It is believed that the amniotic membrane is an immune 
previliged tissue. The epithelium, stroma and fibroblasts of 
cryopreserved amniotic membrane contains HLA class 1 and 2 antigens, 
but the amnion has the ability to suppress alloreactive T cells. 
Furthermore amnion expresses HLA-G, a nonclassic major 
 histocompatibility complex class one molecule expressed in the 
extravillous cytotrophoblast at the feto-maternal interface, that protects 
the fetus from maternal cellular immunity. This antigen along with other 
immunoregulatory molecules plays a role in suppressing the infiltration 
of CD4+ and CD8+ T cells into amnion. 
PREPARATION AND STORAGE: 
         Both in vivo and in vitro studies suggest there is very little 
difference  between fresh and cryopreserved amniotic membrane. The 
amniotic membrane shows little morphological change after 
cryopreservation in 50% glycerol. The cryopreserved membrane is 
typically stored at -80 degree Celsius  on a nitrocellulose paper in 50% 
glycerol with epithelial side up(fig.6).The epithelial side is smooth and 
can be distinguished from the sticky stromal side by touching it with a 
Weck-cel sponge. It can be stained with Lissamine green for better 
visualization of edges and folds during the procedure. The colour returns 
to normal in 120 minutes. 
  
 It is obtained from the placentas of donors undergoing elective 
caesarian section. Donor screening to exclude the presence of HIV 1 and 
2, hepatitis B, hepatitis C, human T lymphocyte virus 1 and 2 and 
syphilis in the donor serum are performed before harvesting the placenta 
and repeated six months later to guard against transmission of blood 
borne pathogens. The placenta is transported under sterile conditions to 
a lamellar –flow hood and cleaned of blood clots with sterile Earle’s 
balanced saline solution containing 50µg/ml of penicillin, 50µ/ml of 
streptomycin,100µ/ml of neomycin and 2.5µg/ml of amphotericin 
(fig.6).The amnion is separated from the chorion by blunt dissection and 
placed on a nitrocellulose paper with the epithelium side up. The 
nitrocellulose paper is then cut in pieces 4 × 4 centimeters and stored at 
-80 degree Celsius in a sterile vial containing Dulbecco’s modified 
Eagle medium and glycerol in the ratio 1:1.If for less than four weeks it 
can be stored at -20 degree Celsius. It is thawed before use. There is also 
a heat dehydrated one which can be stored at room temperature and 
rehydrated with saline minutes before use. It does not need a carrier 
sheet. Both fresh and preserved AM have been found to function equally 
well when transplanted onto the ocular surface. However, there are 
certain concerns when using fresh AM. Ideally, serologic tests on the 
maternal donor must be done both at the time of procurement of the 
 donor tissue and again six months later. This dual testing eliminates the 
slightest risk of disease transmission. With the fresh AM the time 
interval from tissue procurement to transplantation is short and prevents 
repeat testing of the donor. Patients have to be brought to the hospital at 
a short notice unlike with preserved AM, which allows more flexibility 
in scheduling surgery.  A distinct disadvantage is wastage of unused 
tissue with non-preserved AM as opposed to frozen AM where up to 30 
grafts can be prepared from one placenta(26). 
The epithelial cells in fresh or preserved AMG are nonviable. The 
viability of amniotic epithelial cells may be associated with low-grade 
inflammatory response.  The drawback with the preserved AM is the 
need for a -70 o refrigerator, which precludes its use outside big 
institutions.(7) 
  
  
 
 
 
 
 
Fig.6 - Processing and storage of AMG 
 
 SURGICAL TECHNIQUE: 
There are several basic techniques described for amniotic 
membrane transplantation. The clinical indication will indicate the most 
appropriate technique. 
• Graft or inlay technique 
• Patch or overlay technique 
• Grafts (one or more layers ) as a stromal filling technique 
• Ex vivo limbal stem cell transplantation 
Cryopreserved amniotic membrane is usually stored on 
nitrocellulose paper with the stromal (sticky) side down. If there is 
confusion, a blunt forceps can be used to draw up a vitreous like strand. 
GRAFT OR INLAY TECHNIQUE: 
This involves placing a membrane with epithelial side up. One or 
multiple layers are placed depending upon the depth of the defect. The 
membrane is sutured either to the cornea  with 10-0 and bandage contact 
lens then placed. In this technique there is less corneal transparency. The 
inlay technique involves placement of the amniotic membrane graft into 
 the corneal ulcer secured into place by interrupted sutures without 
extending beyond the edge of the epithelial defect. The amniotic 
membrane thus acts as a basement membrane to which epithelialization 
may take place over it from the surrounding epithelium. Therefore, 
persistent corneal defects or ulceration may be treated prior to  or after  
perforation. Mejia, et al. successfully used larger AMT for treatment of 
symptomatic bullous keratopathy by leaving peripheral cornea 
uncovered to promote epithelialization over the graft. They suggested 
that AM used in this fashion may be an alternative to conjunctival flap 
in corneas with poor visual potential. In using this technique, however, 
the amniotic membrane graft becomes trapped under the healed corneal 
epithelium and may limit corneal transparency for several months or 
more affecting vision. (Fig.7) 
PATCH OR OVERLAY TECHNIQUE: 
The amniotic membrane is placed with epithelial side down. In 
the overlay technique, the entire corneal surface including the limbus is 
covered with the amniotic membrane graft. Here the amniotic 
membrane functions primarily as a biological contact lens. The graft 
protects regenerating epithelium from the frictional forces of the eyelid 
and palpebral conjunctiva while at the same time appears to allow 
 adequate oxygen permeability and moisture to the epithelium. Corneal 
transparency remains when the graft eventually detaches or dissolves. 
This method has been used successfully in cases of stem cell deficiency 
of various causes and in cases of persistent epithelial defect 
unresponsive to medical therapy and surgically induced epithelial 
defects. Gris, et al. propose that this method may be a safe alternative 
that some patients may prefer over tarsorrhaphy when medical treatment 
has failed. Both the inlay and overlay techniques may be used 
together(11). (Fig.8) 
LAYERED FILLING TECHNIQUE: 
Several layers of amniotic membrane may be used to pack into a 
deep ulcer cavity. The orientation of the deeper layers appeared to be 
unimportant, the most superficial layer is placed with the basement 
membrane side up. Only the superficial layer needs to be sutured in 
place similar to the inlay technique(18). 
EX VIVO LIMBAL STEM CELL TRANSPLANTATION 
One of the newer and exciting applications of AM has been its 
use as carrier for cultured limbal cells for ocular surface reconstruction 
procedures. It is now accepted that the surface epithelium regenerates 
 from progenitor stem cells located at the limbus (cornea) or fornices 
(conjunctiva), from which new cells migrate and differentiate into 
daughter cells.  
An alternative therapeutic strategy that has been in vogue recently 
is the concept of expanding limbal epithelial cells in vitro using AM as a 
carrier or substrate. Schwab et al . earlier showed with similar technique 
of cultured limbal transplantation in 19 eyes (18 patients) 75% success 
with ocular surface destruction with no complications.   
Expanding corneal epithelial cells from limbal biopsies ex vivo for 
use in ocular surface damage offers many significant advantages. One of 
them being only a small amount of limbal tissue is harvested from the 
uninvolved eye. Conventional limbal allografts require up to 12-clock 
hrs of limbal tissue and have the potential risk for limbal deficiency 
developing in the donor eye. Several studies reported excellent outcome 
of transplantation of cultivated limbal stem cell on denuded AM .  
Amniotic membrane as a carrier in this instance has several 
distinct advantages over the other substrates that have been used. The 
basement membrane of AM contains Type IV collagen and laminin 
which plays an important role in cell adhesion. Further, it acts as a  
  
Fig.7 - Inlay technique 
 
 
Fig.8 -overlay technique 
 
 natural substrate for the cell growth and when transplanted gets 
integrated onto the corneal surface. It also enables easier handling 
during transplantation. Tseng et al . proposed that culturing the explants 
on an intact AM with devitalized epithelium favors expansion of an 
epithelial phenotype that closely resembles limbal stem cells.(7,8)  
CLINICAL APPLICATIONS: 
FOR CONJUNCTIVAL DISEASE: 
• Pterygium 
• Bulbar conjunctival reconstruction after removal of large lesions 
or scars 
• Conjunctivochalasis 
• With or without preserved sclera or pericardium for bleb leakage 
or revision. 
• scleral melt 
• lid reconstruction 
• orbit reconstruction 
  
 FOR CORNEAL DISEASE 
• Persistant corneal epithelial defect with or without ulceration 
• Partial limbal stem cell deficiency 
• Total limbal stem cell deficiency 
• For chemical burns,Steven-Johnsons syndrome 
• Bullous keratopathy with erosion 
• Band keratopathy 
COMPLICATIONS 
 It has an excellent safety profile. Ocular infection is very rare but 
is the most common complication after non preserved amniotic 
membrane transplant. Post-operative complications following the use of 
preserved amniotic membrane is very rare. Hypopion formation in three 
cases have been reported. It was a non-infectious hypopion which 
represents a local immune reaction after sensitization of foreign antigens 
of the previous amniotic membrane from the same donor. Using amnion 
from a different person for a repeat graft will prevent this. Corneal 
calcification were reported in some. Bacterial keratitis with 
Staphylococcus aureus was reported in one case. 
  
 
 
 
 
 
PART - 2 
  
 AIMS OF THE STUDY 
a) To assess the immediate improvement in symptomatology of the 
patient. 
b) To assess the effect of the amniotic membrane in the faster 
healing of ulcers. 
c) To delay or to avoid  the requirement for a therapeutic kertoplasty            
          
 
 
  
 INCLUSION CRITERIA 
 Smear positive uncomplicated bacterial keratitis  
 Smear positive uncomplicated fungal keratitis 
 Mixed ulcers 
 Mild and moderate ulcers 
 
EXCLUSION CRITERIA 
 Descemetocoele 
 Perforated ulcers 
 Viral keratitis,Acanthamoeba keratitis 
 Patients less than eighteen years of age 
 Women of child bearing age 
 Diabetics 
 
 
  
 METHODS AND METHODOLOGY 
The study was conducted at cornea services of the Regional 
Institute of Ophthalmology, Government Ophthalmic hospital, Chennai 
between May 2010 and November 2011. 
21 eyes of 21 patients who underwent Amniotic membrane 
grafting   were included in the study. These patients underwent 
Amniotic membrane grafting for Corneal Ulcers. 
Patients who showed smear positive bacterial and fungal corneal 
ulcers were subjected to single layered   amniotic membrane grafting 
depending on the severity of the ulcer. We did it for mild and moderate 
ulcers. We defined mild ulcers as less than 2 mms in size and involving 
the superficial stroma and moderate ulcers 2-5 mms in size and 
involving the mid-stroma. A thorough slit lamp examination and visual 
acuity testing with. Snellens chart was done pre and post-
operatively.The patients were enquired about the severity of their 
symptoms,more with respect to the severity of their pain.  
Smear was done for all patients presenting with corneal ulcers, 
both gram staining and KOH mount. They were treated with topical 
antibiotics and anti-fungals for one week and then single layered 
 amniotic membrane grafting was done. We used as control a group 21 
almost similar mild and moderate smear positive ulcers with an equal 
distribution of bacterial, fungal and mixed as the study group from the 
year 2008 and 2009 from our old records and comparisons were made. 
The membrane was obtained from the placentas of patients undergoing 
elective lower segment caesarian section from the institute of obstetrics 
and gynaecology after screening for hepatitis B and HIV.  
Under peribulbar block, the ulcer was first debrided. A suitable 
size of the amniotic membrane was cut such that it could cover the 
entire cornea and a few millimeter of the conjunctiva. The overlay 
technique was used. A few pricks were made in the membrane before 
placing it on the cornea using a 26G needle to prevent air locking behind 
the membrane and the membrane lifting up. The membrane was then 
placed on the cornea and then sutured to the conjunctiva with 10-0.A 
pad and bandage was applied. The eye was patched for 24 hours and 
then antibiotics were continued. The graft was found to be retained for 
an average of five days after which it sloughed. The conjunctival sutures 
were then removed  History regarding the patients symptoms both pre 
and post operatively mainly pain, was taken into account to determine 
symptomatic improvement which was the primary aim of the study. 
 Redness and photophobia were also considered and the patient was 
examined under slit lamp regularly, to look for signs of healing. Visual 
aquity testing was also repeated after five days. The symptoms were 
graded as follows. 
Grades of pain :  
Grade 0 ; no pain ,  
Grade 1; occasional mild pain, 
Grade 2; constant mild pain,  
Grade 3; moderate to severe pain, 
Grade 4 ; constant severe pain. 
Grades of redness :  
Grade 0 ; no redness,  
Grade 1; redness in one quadrant, 
Grade 2; redness in two quadrants, 
Grade 3; redness in four quadrants,  
Grade 4; redness all around 
Grades of photophobia :  
Grade 0; no photophobia,  
Grade 1 ; photophobia only in bright light, 
Grade 2; photophobia in day light, 
     Grade 3; photophobia in dim light,  
Grade 4; photophobia without light. 
 Ulcers complicated by descematocoele and perforated ulcers were 
excluded from the study. Viral keratitis was not included. Known 
diabetics and newly diagnosed diabetics with fasting blood sugar more 
than 130 milligrams were also excluded.  
Women of child bearing age were not taken. Visual acuity with 
Snellen’s chart, corneal smear, slit-lamp photography was done pre and 
post-procedure. The patient history regarding an improvement in 
symptoms was taken the next day and the patient was observed for signs 
of healing. The patients were followed up over a period of 
3months.Most of them were lost from follow up. 
  
 OBSERVATION AND ANALYSIS 
Table - 2 : IMPROVEMENT IN SYMPTOMS 
  
Group 
Total 
Control Study 
Symptom  
(Pain) -  
Post op 
No pain 
Count 0 2 2 
% within Symptom 
(Pain) - Post op .0% 100.0% 100.0% 
% within Group .0% 9.5% 4.8% 
Occasional mild 
pain 
Count 5 10 15 
% within Symptom 
(Pain) - Post op 33.3% 66.7% 100.0% 
% within Group 23.8% 47.6% 35.7% 
Constant mild 
pain 
Count 2 5 7 
% within Symptom 
(Pain) - Post op 28.6% 71.4% 100.0% 
% within Group 9.5% 23.8% 16.7% 
Moderate 
Count 9 3 12 
% within Symptom 
(Pain) - Post op 75.0% 25.0% 100.0% 
% within Group 42.9% 14.3% 28.6% 
Severe 
Count 5 1 6 
% within Symptom 
(Pain) - Post op 83.3% 16.7% 100.0% 
% within Group 23.8% 4.8% 14.3% 
Total 
Count 21 21 42 
% within Symptom 
(Pain) - Post op 50.0% 50.0% 100.0% 
% within Group 100.0% 100.0% 100.0% 
 
In the study group 2 patients showed a complete absence of pain 
following the procedure.71.4% of the patients had only mild pain. There 
was a significant reduction in the patients who had severe pain. It 
reduced from 47.6% pre-operatively to 4.8%. post-operatively. 
  
 
 
 
Table – 3 : RATE OF HEALING 
 Group N Mean Std. Deviation Std. Error Mean 
No. of Days of 
Healing 
Control 6 19.00 3.162 1.291 
Study 13 9.08 2.431 .674 
 
In the group with AMG, healed ulcers took an average of 9.08 
days to do so, where as the group with no AMG took 19 days to heal. 
By chi square test it was statistically significant. p<0.001 
  
  
Table – 4 : OUTCOME OF THE PATIENTS 
  
Group 
Total 
Control Study 
Outcome 
healed 
Count 6 13 19 
% within Outcome 31.6% 68.4% 100.0% 
% within Group 28.6% 61.9% 45.2% 
TKP 
Count 15 8 23 
% within Outcome 65.2% 34.8% 100.0% 
% within Group 71.4% 38.1% 54.8% 
Total 
Count 21 21 42 
% within Outcome 50.0% 50.0% 100.0% 
% within Group 100.0% 100.0% 100.0% 
 
The need for a therapeutic keratoplasty in the study group 
decreased. There was a 33% reduction in the need for a TKP. P <0.03 by 
chi square test, which was significant. 
  
 DISCUSSION 
With a view to achieving rapid epithelialization and immediate 
symptomatic relief by covering the raw surface with exposed nerve  
endings directly by amniotic membrane, we ventured to take up the  
present study. We were led to the idea of trying this membrane in  cases 
of corneal ulcers, more so because any material which does not  behave 
as a foreign body over the eye should provide the most suitable  
coverage material. It has an added advantage that it can be easily 
prepared and stored in any hospital or laboratory. 
Prior to inserting such a graft it is of utmost importance to combat 
the infection because this immediate covering material worsens the con-
dition of an ulcer, if it is grossly infected or sloughing. 
From the above data it was very remarkable to find such quick 
relief of pain. There was an immediate relief in symptoms in the first 
two hours, this relief of pain was due to the effect of anaesthesia but 
later on when the effect wore off  84% per cent of the patients showed a 
remarkable improvement in symptoms (Fig.10). This cause of 
immediate relief of pain in these cases must be due to the protective 
covering over the exposed nerve endings of the ulcerated corneal 
 surface. This immediate covering material probably acted by not 
allowing any irritant, mechanical, chemical or toxic to reach the nerve 
endings. The cases where pain was continued for a longer period may be 
due to an inflammation of the iris. In the control group only 33.33% of 
the patients had an improvement in symptoms after topical antibiotics 
alone. 
In cases where amniotic membrane grafting was done there was 
marked reduction in the healing time. The average healing time came 
down to 9.08 days as against  19  days in control cases (Fig.13).This 
time was  calculated from one week of application of topical medication 
after which grafting was carried out and antibiotics continued in the 
control group.  A healing of the epithelial defect and absence of the 
infiltrate and circum-corneal injection with scarring were taken as 
indicators of healing. The various factors present in the membrane was 
probably the reason for this. Besides, as the ulcer is protected, the 
mitosis of corneal cells and production of fibroblasts to fill up the ulcer 
proceeded unimpaired. Moreover the mechanical trauma on the diseased 
cornea by blinking of the lids is also eliminated, thus allowing the 
process of healing to proceed unimpaired or even to hasten. Thus 
increased metabolic activity, and avoidance of irritants may be factors in 
 enhancing the healing process. In our series of clinical cases it was 
obvious that the healing process was definitely quickened by the 
grafting. Out of the 21 cases in the study group 9 were bacterial, 7 
fungal and 5 mixed ulcers (Fig.9). 13 cases healed and 8 underwent a 
TKP.  
Among the ones that healed there were 7 bacterial (77.77%), 4 
fungal (57.14%) and 2 mixed (40%)  (Fig.12). In these cases the graft 
probably reduced the chances of a perforation by maintaining the 
tectonicity of the globe for some time and delayed the emergent need for 
a TKP and thereby  helped us, as the supply of donor eyes is still not 
meeting our requirements.Our study shows a better response with 
respect to bacterial ulcers. Of the control group, in 6 patients the ulcer 
healed and 15 patients underwent a TKP of which three perforated 
before we could undertake one.(Fig.11) Of the healed ulcers 3 were 
fungal, 2 bacterial and 1 mixed. 
Visual outcome was not taken into account in either groups. Some 
of them in the study group even showed a decrease in vision due to the 
formation of thick opacities due to healing.  In the control group also we 
took mild and moderate ulcers with an equal distribution of bacterial, 
fungal and mixed as the study group. 
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 Table- 6 : SYMPTOMATIC IMPROVEMENT
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NO AMG 
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Fig.10 - SYMPTOMATIC IMPROVEMENT
NO. PERCENTAGE
13 84%
6 33%
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              TABLE  - 7 : RESPONSE TO TREATMENT
 
AMG 
NO AMG 
38%
71%
 
HEALED TKP
62% 38%
29% 71%
 
 
62%
Fig.11- AMG
Healed ulcer TKP
29%
NO AMG
Healed ulcer TKP
 
 
 
 
 
 
 Table – 8: Rate of Healing of the Different Ulcers 
Etiology 
Study Group Control Group 
Total Healed % Total Healed % 
Bacterial 9 7 77.77% 9 2 22.22% 
Fungal 7 4 57.14% 7 3 42.8% 
Mixed 5 2 40% 5 1 20% 
 
 
                           
77.7
57.1
40
22.2
42.8
20
0
10
20
30
40
50
60
70
80
90
Bacterial Fungal Mixed
Pe
rc
n
ta
ge
Fig.12 - RATES OF HEALING OF THE  DIFFERENT ULCERS
Study Group Control Group
  
 
 
 
 
0
2
4
6
8
10
12
14
16
18
20
WITH AMG
9.08
Fig.13
 
WITHOUT AMG
19
- DAYS FOR HEALING
WITH AMG WITHOUT AMG
 
 
 REVIEW OF LITERATURE 
A similar study was performed by Jae-Soon Kim,et al in the year 
2010. A prospective study of 21 consecutive eyes (21patients) was 
performed. Sufficient antibacterial, antifungal, or antiviral agents were 
applied to eradicate causative organisms before permanent or temporary 
amniotic membrane transplantation, or a combination of the two in few 
patients. The amniotic membrane was soaked in antiinfective agents 
before transplantation. The follow up ranged  from 4 to 28 months 
(mean, 18 months). They included even viral and Acanthamoeba 
keratitis.The corneal surface was healed successfully and recurrences of 
microbial infection were not noted in any case. Visual acuity was 
improved in cases that were nonscarring or after additional penetrating 
keratoplasty.They concluded that Amniotic membrane transplantation 
seemed to be a useful adjunctive surgical  procedure for the 
management of infectious corneal ulcer by promoting wound healing 
and reducing inflammation. 
Shukla IMet al conducted a similar study in 72 patients, Indian J 
Ophthalmol 1962  but he applied it on both superficial and deep ulcers. 
In superficial ulcer group the average healing time came down to 6 days 
as against 11.8 days in control cases and similarly in deep ulcer cases 
 the average time came down from 19.5 days to 9.6 days where grafts 
were applied on. 
In our study we have taken only superficial ulcers. In our study, 
the time for healing was 9.2 days as against 18.7 days in the control 
group. We have taken only ulcers of bacterial, fungal and mixed 
etiology. 
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CONCLUSION 
Our study proves that amniotic membrane grafting is indeed an 
effective treatment modality in ulcers especially in providing 
symptomatic relief. It reduces the time required for healing and thereby 
prevents the various complications associated with  non healing ulcers. 
The need for a therapeutic keratoplasty is significantly low and thereby 
the various complications associated with it may also be avoided.. 
Though some of our patients showed  really thick opacities probably an 
effect of the amniotic membrane itself, this is of no consequence as an 
optical keratoplasty can be undertaken later with respect to improving 
vision.  The  response seems to be better with respect to bacterial 
corneal ulcers.   
As the amniotic membrane is easily available and there are no 
complications associated, it proves to be a useful measure for the 
treatment of corneal ulcers.     
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 PROFOMA 
Name ; 
Date : 
Address ;  
Age : 
Sex : 
Date of admission : 
Date of discharge : 
IP number :  
Complaints 
     Pain-severity : 
Present history : 
Past history : 
Family history : 
History of diabetes mellitus and hypertension 
General examination 
 
  
 LOCAL EXAMINATION (both eyes) 
Visual axis 
Uncorrected and Best corrected visual acuity 
Lids and adnexa 
Conjunctiva 
Cornea-epithelial defect, depth of infiltrate 
Anterior chamber-presence or absence of inflammation 
Iris 
Pupil 
Fundus 
Intraocular pressure 
Corneal smear 
Blood sugar 
Blood sugar 
Urine-albumin, sugar 
Syringing of the Nasolacrimal duct 
At each visit-Visual acuity 
                        Slit lamp 
                         
 
MASTER CHART
Vn
SYMPTOMS
(PAIN)
DAY OF 
HEALING
PRE-OP POST-OP PRE-OP POST-OP
1) Kanniammal 67 F 05-07-2010 14/5/10 F 4/60ph6/60 4/60nip 4 1 0 12
2) Venkatesh 28 M 21/5/10 28/5/10 B 6/36nip 6/36nip 3 1 1
3) Veeraya 60 M 06-03-2010 06-10-2010 F 6/60ph6/36 6/60nip 3 1 0 9
4) Palani 54 M 17/6/10 24/6/10 F 2/60nip 4/60nip 4 4 1
5) Mary 61 F 20/7/10 27/7/10 M 4/60ph6/60 6/60ph6/36 4 1 0 13
6) Muniammal 63 F 21/8/10 28/8/10 B 5/60nip 4/60nip 4 1 0 12
7) Ponniah 51 M 09-04-2010 09-11-2010 F 2/60nip HM 3 3 1
8) Malakondaiya 68 M 10-03-2010 10-10-2010 B 3/60nip 2/60PH6/60 4 1 0 7
9) Mari 41 M 10-08-2010 15/10/10 M 4/60nip 2/60NIP 3 1 1
10) Devan 65 M 03-03-2011 03-10-2011 M 1/60nip 1/60NIP 4 2 1
11) Mariammal 52 F 15/5/11 22/5/11 B 6/60ph6/36 6/36PH6/18 3 1 0 8
12) Chengalvarayalu 45 M 21/5/11 28/5/11 M 6/60ph6/36 6/18PH6/12 3 0 0 5
13) Veerasamy 67 M 06-04-2011 06-11-2011 B 6/36nip 6/24PH6/12 3 2 0 8
14) Ponniah 72 M 06-11-2011 18/6/11 F 3/60nip HM 3 4 1
15) Devi 41 F 15/7/11 22/7/11 F CFCF 4/60NIP 4 2 0 10
16) Udhayakumar 40 M 20/9/11 27/9/11 B 6/60ph6/36 6/60PH6/24 2 0 0 6
17) Ponnan 69 M 09-08-2011 14/9/11 F 6/36nip 6/36PH6/12 4 2 0 8
18) Velu 64 M 23/9/11 29/9/11 M 5/60nip 6/60ph6/36 4 3 1
19) Ravi 38 M 28/9/11 10-05-2011 B 4/60ph6/60 4/60NIP 4 1 0 9
20) Parameshwari 35 F 28/9/11 10-05-2011 B 6/36ph6/24 6/12ph6/9 3 1 0 11
21) Esther 73 F 11-06-2011 13/11/11 B 2/60nip HM 3 3 1
S.
No.
OUTCOMESMEARDOSDOASEXAGEName
STUDY GROUP
MASTER CHART
Vn
SYMPTOMS
(PAIN)
DAY OF 
HEALING
PRE-OP POST-OP PRE-OP POST-OP
S.
No.
OUTCOMESMEARDOSDOASEXAGEName
1) Raman 47 05-01-2008 B 4/60NIP 6/36NIP 3 1 0 17
2) Mary 51 06-07-2008 F 6/60PH6/36 6/60NIP 3 4 1
3) Muniammal 55 23/6/08 F 5/60NIP 5/60NIP 4 4 1
4) Kaniammal 67 07-03-2008 F 6/60NIP 6/60NIP 3 3 1
5) Rahman 41 07-05-2008 F 3/60PH4/60 3/60PH5/60 2 1 0 19
6) Lakshmi 52 08-06-2008 M 6/60PH6/36 6/60NIP 3 3 1
7) Manikandan 61 31/8/08 F 6/36NIP 6/36NIP 3 4 1
8) Manickam 67 22/9/08 M 6/60NIP 6/60NIP 2 3 1
9) Veeralakshmi 56 27/9/08 B 2/60NIP 6/60PH6/36 2 1 0 15
10) Suresh 59 10-07-2008 B 3/60PH6/60 3\60NIP 2 3 1
11) Seemati 60 17/10/08 M 6/60NIP 6/60PH6/36 2 3 1
12) Kruppan 63 21/11/08 B 6/36NIP 6/60NIP 3 3 1
13) Jeevan 51 12-05-2008 M 4/60PH6/60 6/36PH6/24 3 4 1
14) Ponnan 67 01-03-2009 M 4/60NIP HM 4 1 0 21
15) Kasthuri 49 02-05-2009 B 3/60PH6/60 6/60NIP 2 3 1
16) Kaliyaperumal 62 21/3/09 F 3/60NIP 2/60NIP 2 2 1
17) Dasran 55 16/4/09 F 4/60PH6/36 6/36PH6/24 4 3 0 24
18) Maran 60 05-12-2009 B 4/60PH6/60 6/24PH6/18 4 2 0 18
19) Lakshmi 71 19/5/09 B 6/36NIP 4/60PH6/60 3 1 1
20) Paramehwari 57 26/6/09 B 3/60NIP CFCF 3 4 1
21) Muniammal 53 08-07-2009 B 2/60NIP HM 2 3 1
Key to master chart-
CONTROL GROUP
MASTER CHART
Vn
SYMPTOMS
(PAIN)
DAY OF 
HEALING
PRE-OP POST-OP PRE-OP POST-OP
S.
No.
OUTCOMESMEARDOSDOASEXAGEName
Smear,F-fungal,B-bacterial,M-mixed.OUTCOME-0-HEALED,1-Therapeutic keratoplasty,PAIN,0-no pain,1-occasional mild pain,2-constant mild pain,3-moderate pain,4-severe pain.
KEY TO MASTER CHART 
SMEAR 
F-fungal, 
B-bacterial, 
M-mixed 
 OUTCOME 
-0-HEALED 
1-Therapeutic keratoplasty 
 PAIN, 
0-no pain, 
1-occasional mild pain, 
2-constant mild pain, 
3-moderate pain, 
4-severe pain  
Vn-vision 
CFCF-counting fingers close to face. 
HM-Hand movements 
 
 
